• Home
  • About
    • Psychedelic For Healthy People
    • Psilocybin (Magic Mushrooms)
    • Ayahuasca (Chacruna – Kaapi – Yajé)
    • MDMA (MDA – Sassafras)
    • Peyote Mescaline (Huachuma)
    • Kambo – Amazonian Frog
    • 5-MeO-DMT (Toad Medicine)
    • Rapé And Sacred Tobacco
    • Iboga (Ibogaine)
    • LSD (Lysergic Acid Diethylamide)
    • Cannabis (Marijuana)
    • Ketamine
    • Psychedelic Integration
    • Psychedelics Advocates
    • Frequently Asked Questions
    • Mental Health Symptoms
    • Substances Test Kits
    • Manifesto
  • Treatments
    • Latest Psychedelic Research
    • Addiction
    • Alcoholism
    • Anxiety
    • Bipolar Disorder
    • Cancer
    • Cluster Headaches
    • Depression
    • End Of Life
    • OCD
    • Neuropathy
    • Pain
    • Parkinson’s Disease
    • PTSD
    • Smoking
    • Help Treat Mental Illness
  • Microdosing
    • What is Microdosing?
    • Microdosing Magic Mushrooms
    • Microdosing LSD
    • Microdosing MDMA
    • Microdosing Ayahuasca
    • Microdosing Mescaline
    • Microdosing Cannabis
    • Microdosing Ibogaine
  • Resources
    • Past Events
    • ALL Locations
    • DMT Psychoactive Plants
    • Medical Trials And Research
    • Psychedelic Research
    • EntheoPodcasts
    • In The News
    • Books On Psychedelics
    • Related Videos
    • EntheoResources
    • Terence McKenna
    • What Is Psychedelic Art?
    • Useful Links
    • Movies & Documentaries
    • Michael Pollan
Contact
  • Follow
  • Follow
  • Follow
  • Follow
Is it Possible to Create an Ethical Psychedelics Company?

Is it Possible to Create an Ethical Psychedelics Company?

by EmpathiCSubstanceS | Nov 9, 2021 | Cancer, CBC, Cluster Headaches, Depression, MDMA Sassafras Molly, Neuropathy, NN-Dimethyltryptamine

At a virtual investment conference last week called Psychedelic Capital, the moderator of a session on ethical intellectual property opened the panel by asking, “To patent or not patent? That is the question.” That certainly is the question that’s been hotly debated...
Is it Possible to Create an Ethical Psychedelics Company?

Do Psychedelics Just Provide Comforting Delusions?

by EmpathiCSubstanceS | Nov 8, 2021 | Addiction, Alcoholism, Ayahuasca, Cancer, Cluster Headaches, Depression, Iboga, Kambo, Parkinson's Disease, Psychotropics

And if so, does it matter? In a new book, philosopher Chris Letheby confronts the nature and implications of the mystical experiences people often have while taking psychedelics. There’s an “elephant in the room” of psychedelic science, according to an opinion...
Is it Possible to Create an Ethical Psychedelics Company?

Can LSD Treat Food Allergies?

by EmpathiCSubstanceS | Nov 8, 2021 | Anxiety, Bipolar Disorder, Cannabis Marijuana, Chronic Pain, Depression, Kambo, LSD, NN-Dimethyltryptamine, Pain, San Pedro Mescaline

We Don’t Know, But It’s Already Been Patented. In 2001, alternative medicine proponent and doctor Andrew Weil told a CBS journalist that taking LSD cured his lifelong cat allergy. “I was in a wonderful outdoor setting,” Weil said. “I felt terrific and, in the midst of...
Is it Possible to Create an Ethical Psychedelics Company?

How to Set an Intention for Your Drug Trip?

by EmpathiCSubstanceS | Nov 8, 2021 | Anxiety, Bipolar Disorder, Cannabis Marijuana, Chronic Pain, Depression, Iboga, Kambo, MDMA Sassafras Molly, Microdosing

A recent mushrooms-and-MDMA trip wasn’t elucidating in the way I’d hoped it might be. I chose to record myself doing psychedelics with a guide, hoping that when I listened back, I’d hear myself having major breakthroughs. What this actually sounded like, when I...
Is it Possible to Create an Ethical Psychedelics Company?

How Long Does DMT Stay In Your System?

by EmpathiCSubstanceS | Nov 8, 2021 | Addiction, Bipolar Disorder, Chronic Pain, Depression, MDMA Sassafras Molly, Neuropathy, Pain, PTSD

DMT (N, N-Dimethyltryptamine) is an endogenous hallucinogen or drug, which means it’s a substance that’s common in living organisms like plants and can cause mind-altering side effects. Because DMT drug effects are often psychedelic and include symptoms like...
« Older Entries
Next Entries »

IMPORTANT NOTICE:

This community is being designed as a secure space. It is not a place to seek, encourage, or participate in the procurement of controlled substances. Do not bring, buy, sell, transfer, or arrive on any illegal substances, or swap information on how to buy them. Attendees and/or members of this community who violate these basic house rules will be removed from the community and will not be allowed to attend future events.

Psychedelic Research

Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study

Aug 11, 2022

Nonparametric comparisons via Friedman Test between baseline and 12-month follow-up for participants completing all interviews (n = 8) showed a significant reduction for the ASI-Lite drug use (p = 0.002) composite score. Reductions in BDI-II scores from baseline to...

Psychiatry’s next top model: Cause for a re-think on drug models of psychosis and other psychiatric disorders

Aug 11, 2022

In the first part, mental health professionals associated statements referring to specific experiences, for example 'I don't bother to get out of bed', to one or more psychiatric symptom clusters, for example depression and negative psychotic symptoms. This measured...

Effects of psilocybin therapy on personality structure

Aug 11, 2022

Neuroticism scores significantly decreased while Extraversion increased following psilocybin therapy. These changes were in the direction of the normative NEO‐PI‐R data and were both predicted, in an exploratory analysis, by the degree of insightfulness experienced...

Psychedelic Medicine

Principles to Make the Most of Your Psychedelic Experience: Set and Setting

Apr 13, 2020

When I recently had the opportunity to talk with a psychedelic integration specialist, we discussed all kinds of topics—addiction, anxiety, mindfulness, and, of course, psychedelic experiences. With several years under his belt as a recovery coach and integration...

How to Describe Your Psychedelic Experience Using Shulgin’s Rating Scale

Apr 13, 2020

Experienced psychonauts are aware of the fact that the psychedelic space can sometimes be tricky to navigate, and know that it is helpful to have techniques available to assist with that effort. Accurately identifying the intensity of an experience can help while the...

Who is Terence McKenna?

Apr 9, 2020

[vc_row type="in_container" full_screen_row_position="middle" scene_position="center" text_color="dark" text_align="left" overlay_strength="0.3" shape_divider_position="bottom"][vc_column column_padding="no-extra-padding" column_padding_position="all"...

Psychedelic Law Reform

Apr 8, 2020

[vc_row type="in_container" full_screen_row_position="middle" scene_position="center" text_color="dark" text_align="left" overlay_strength="0.3" shape_divider_position="bottom"][vc_column column_padding="no-extra-padding" column_padding_position="all"...

Psilocybin Initiative: Update on Implementation and Implication for Future Psychedelic Decriminalization Initiatives

Apr 8, 2020

[vc_row type="in_container" full_screen_row_position="middle" scene_position="center" text_color="dark" text_align="left" overlay_strength="0.3" shape_divider_position="bottom"][vc_column column_padding="no-extra-padding" column_padding_position="all"...

© 2025| All Rights Reserved, EntheoMedicine Community
  • Follow
  • Follow
  • Follow
  • Follow